跳至主要内容
临床试验/NCT02078011
NCT02078011已完成不适用

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU): A Feasibility Study

David R. Brenin, MD2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
2
主要终点
Size of fibroadenoma

研究概览

简要总结

The purpose of this study is to test an investigational device called the Echopulse for treatment of breast fibroadenomas in women. Fibroadenomas are benign (noncancerous) breast tumors that are made of glandular and fibrous breast tissue. These lumps can occur alone, in groups, or as a complex of lumps together. Sometimes women feel these in the breast when doing regular self breast exams, or they may be found during a routine mammogram. Some are small (less than an inch in size), and others are quite large (the size of a lemon or larger).

This is a study about the Echopulse device, a computer driven system which uses ultrasound to guide a high intensity focused ultrasound beam to a targeted area (the fibroadenoma in the breast). The high intensity focused ultrasound (HIFU) heats the targeted site which causes the cells to die and allows the possibility to treat the fibroadenoma without the need for surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Diagnosis of fibroadenoma with histological confirmation of fibroadenoma of the breast
  • Fibroadenoma is palpable
  • Fibroadenoma is 1 cm or greater at its largest dimension and no less than 9 mm in the anterior-posterior dimension
  • Fibroadenoma volume is between 2 cc and 10 cc
  • Patient must give written informed consent (personally signed and dated) before completing any study-related procedure

排除标准

  • Patient is pregnant or nursing
  • Patient with breast implants in the target breast
  • Patient with a breast cyst within the fibroadenoma to be treated
  • Patient participating in another clinical trial involving an investigational drug, device or biologic

研究组 & 干预措施

HIFU treatment

Experimental

The high intensity focused ultrasound (HIFU) will be administered to the targeted site to create heat and cause the cells to die

干预措施: High Intensity Focused Ultrasound (Device)

结局指标

主要结局

Size of fibroadenoma

时间窗: baseline, 3, 6, and 12 months

Fibroadenoma will be assessed by physical examination including measurement of tumor size at clinic visits.

Patient reported outcomes

时间窗: up to 12 months

Patient-rated pain and patient responses to Satisfaction Questionnaire will be measured at intervals up to 12 months following HIFU treatment session

Change in volume of fibroadenoma

时间窗: baseline, 3, 6, and 12 months

Fibroadenoma volume with be measured by ultrasound.

次要结局

  • Incidence of adverse events(up to 12 months)

研究者

发起方
David R. Brenin, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

David R. Brenin, MD

Associate Professor, Department of Surgery

University of Virginia

研究点 (2)

Loading locations...

相似试验